US News

Astra antibody cocktail fails to prevent COVID-19 symptoms in large trial

Published by
Reuters

By Vishwadha Chander and Ludwig Burger (Reuters) -AstraZeneca said on Tuesday a late-stage trial failed to provide evidence that its COVID-19 antibody therapy protected people who had contact with an infected person from the disease, a small setback in its efforts to find alternatives to vaccines. The study assessed whether the therapy, a cocktail of two types of antibodies, could prevent adults who had been exposed to the virus in the past eight days from developing COVID-19 symptoms. The therapy, AZD7442, was 33% effective in reducing the risk of people developing symptoms compared with a pl…

Read More

Facebook Comments

Check Also

German chancellor candidate opposes Greens’ climate ministry plan

Published by DPA Armin Laschet, the conservative contender ...

Archives